Does The Street Have Mead Johnson Nutrition Figured Out?

Before you go, we thought you'd like these...
Before you go close icon

Mead Johnson Nutrition (NYS: MJN) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Mead Johnson Nutrition's revenues will increase 2.8% and EPS will expand 1.2%.

The average estimate for revenue is $1.04 billion. On the bottom line, the average EPS estimate is $0.84.


Revenue details
Last quarter, Mead Johnson Nutrition booked revenue of $1.04 billion. GAAP reported sales were 5.2% higher than the prior-year quarter's $986.6 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $0.85. GAAP EPS of $0.85 for Q1 were 6.3% higher than the prior-year quarter's $0.80 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 62.3%, 20 basis points better than the prior-year quarter. Operating margin was 25.2%, 60 basis points worse than the prior-year quarter. Net margin was 16.6%, much about the same as the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $4.13 billion. The average EPS estimate is $3.25.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 83 members out of 103 rating the stock outperform, and 20 members rating it underperform. Among 37 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 29 give Mead Johnson Nutrition a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mead Johnson Nutrition is hold, with an average price target of $79.29.

Selling to fickle consumers is a tough business for Mead Johnson Nutrition or anyone else in the space. But some companies are better equipped to face the future than others. In a new report, we'll give you the rundown on three companies that are setting themselves up to dominate retail. Click here for instant access to this free report.

The article Does The Street Have Mead Johnson Nutrition Figured Out? originally appeared on Fool.com.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners